Treatment outcomes and patient-reported quality of life after orthognathic surgery with computer-assisted 2-or 3-dimensional planning: A randomized double-blind active-controlled clinical trial

被引:21
|
作者
Bengtsson, Martin [1 ]
Wall, Gert [1 ]
Larsson, Pernilla [2 ,3 ]
Becktor, Jonas P. [4 ]
Rasmusson, Lars [5 ]
机构
[1] Univ Hosp Skane, Dept Oral & Maxillofacial Surg, S-22185 Lund, Sweden
[2] Ostergotland Cty Council, Ctr Oral Rehabil, Linkoping, Sweden
[3] Malmo Univ, Fac Odontol, Dept Orofacial Pain & Jaw Funct, Malmo, Sweden
[4] Malmo Univ, Fac Odontol, Dept Oral & Maxillofacial Surg & Oral Med, Malmo, Sweden
[5] Gothenburg Univ, Sahlgrenska Acad, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden
关键词
OROFACIAL AESTHETIC SCALE; CAD/CAM SURGICAL SPLINTS; DISTRACTION OSTEOGENESIS; PROSTHODONTIC PATIENTS; SWEDISH VERSION; ACCURACY; SIMULATION; IMPACT; RELIABILITY; VALIDITY;
D O I
10.1016/j.ajodo.2017.12.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: Thorough treatment planning is essential for a good clinical outcome in orthognathic treatment. The planning is often digital. Both 2-dimensional (2D) and 3-dimensional (3D) software options are available. The aim of this randomized 2-arm parallel double-blinded active-controlled clinical trial was to comprae the outcomes of computer-based 2D and 3D planning techniques according to patient-reported health related quality of life. The hypothesis was that a 3D technique would give a better treatment outcome compared with a 2D technique. Methods: Orthognathic treatment for 62 subjects, aged 18 to 28 years, with severe Class III malocclusion was planned with both 2D and 3D techniques. After treatment planning but before surgery, the patients were randomly allocated via blind collection of 1 enveloped card for each subject in a 1:1 ratio to the test (3D) or the control (2D) group. Thus, the intervention was according to which planning technique was used. The primary outcome was patient-reported outcome measures. The secondary outcome was relationship between patient-reported outcome measures and cephalometric accuracy. Questionnaires on the patient's health-related quality of life (HRQoL) were distributed preoperatively and 12 months after surgical treatment. The questionnaires were coded, meaning blinding throughout the analysis. Differences between groups were tested with the Fisher permutation test. The HRQoL was also compared with measurements of cephalometric accuracy for the 2 groups. Reslts: Three subjects were lost to clinical follow-up leaving 57 included. Of these, 55 subjects completed the questionnaires, 28 in the 2D and 27 in the 3D groups. No statistically significant difference regarding HRQoL was found between the studied planning techniques: the Oral Health Impact Profile total showed -3.69 (95% confidence interval, -19.68 to 12.30). Consistent results on HRQoL and cephalometric accuracy showed a difference between pretreatment and postreatment that increased in both groups but to a higher level in the 3D group. A difference between pretreatment and posttreatment HRQoL was shown for both groups, indicating increased quality of life after treatment. This supports recent findings comparing 3D and 2D planning techniques. No serious harm was observed during the study. Conclusions: Improvemens of HRQoL were shown after treatment independent of which planning technique, 2D or 3D, was used. No statisticaly significant difference was found between the planning techniqes. Registration: This trial was not registered. Protocol: The protocol was not published before trial commencement.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 47 条
  • [41] Treatment of severe periodontitis with a laser and light-emitting diode (LED) procedure adjunctive to scaling and root planing: a double-blind, randomized, single-center, split-mouth clinical trial investigating its efficacy and patient-reported outcomes at 1 year
    Giannelli, Marco
    Materassi, Fabrizio
    Fossi, Tiziana
    Lorenzini, Luca
    Bani, Daniele
    LASERS IN MEDICAL SCIENCE, 2018, 33 (05) : 991 - 1002
  • [42] Treatment of severe periodontitis with a laser and light-emitting diode (LED) procedure adjunctive to scaling and root planing: a double-blind, randomized, single-center, split-mouth clinical trial investigating its efficacy and patient-reported outcomes at 1 year
    Marco Giannelli
    Fabrizio Materassi
    Tiziana Fossi
    Luca Lorenzini
    Daniele Bani
    Lasers in Medical Science, 2018, 33 : 991 - 1002
  • [43] DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB WAS ASSOCIATED WITH IMPROVEMENTS IN PATIENT-REPORTED AND QUALITY-OF-LIFE OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 2B, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY
    van der Heijde, Desiree
    Gensler, Lianne S.
    Deodhar, Atul
    Baraliakos, Xenofon
    Poddubnyy, Denis
    Farmer, Mary Katherine
    Baeten, Dominique
    Coarse, Jason
    Oortgiesen, Marga
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 193 - 193
  • [44] IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND WORKPLACE AND HOUSEHOLD PRODUCTIVITY FOLLOWING 52 WEEKS OF TREATMENT WITH CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN DMARD-NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS: RESULTS FROM THE C-EARLY RANDOMIZED, DOUBLE-BLIND, CONTROLLED PHASE 3 STUDY
    Emery, P.
    Bingham, C. O.
    Burmester, G. -R.
    Bykerk, V. P.
    Furst, D. E.
    Mariette, X.
    Purcaru, O.
    Coteur, G.
    VanLunen, B.
    Weinblatt, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 712 - 713
  • [45] A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)
    Leng, Xiaomei
    Leszczynski, Piotr
    Jeka, Slawomir
    Liu, Shengyun
    Liu, Huaxiang
    Miakisz, Malgorzata
    Gu, Jieruo
    Kilasonia, Lali
    Stanislavchuk, Mykola
    Yang, Xiaolei
    Zhou, Yinbo
    Dong, Qingfeng
    Mitroiu, Marian
    Addison, Janet
    Rezk, Mourad F.
    Zeng, Xiaofeng
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [46] Fixation using Alternative Implants for the Treatment of Hip Fractures (FAITH-2): The Exploratory Health-Related Quality of Life and Patient-Reported Functional Outcomes of a Multi-Centre 2 x 2 Factorial Randomized Controlled Pilot Trial in Young Femoral Neck Fracture Patients
    Slobogean, Gerard P.
    Sprague, Sheila
    Bzovsky, Sofia
    Scott, Taryn
    Thabane, Lehana
    Heels-Ansdell, Diane
    O'Toole, Robert, V
    Howe, Andrea
    Gaski, Greg E.
    Hill, Lauren C.
    Brown, Krista M.
    Viskontas, Darius
    Zomar, Mauri
    Della Rocca, Gregory J.
    O'Hara, Nathan N.
    Bhandari, Mohit
    Malekzadeh, A. Stephen
    Nauth, Aaron
    Perdue, Aaron
    Mamun, Abdullah
    Wasim, Abeer
    Klein, Adam
    Brandon, Adrienne
    Theriault, Aimee
    Garibaldi, Alisha
    Liew, Allan
    Atrey, Amit
    Lialios-Ramfos, Anastasia
    Spiguel, Andre
    Howe, Andrea
    Howe, Andrea L.
    Furey, Andrew
    Marcantonio, Andrew J.
    Pollak, Andrew N.
    Schmidt, Andrew
    Dowbenka, Ann
    Mak, Anne
    Sorkin, Anthony T.
    Sivananthan, Araby
    Buck, Ashley
    Okocha, Benita
    Frye, Benjamin
    Perey, Bertrand
    Mohan, Bindu
    Eyberg, Blake
    Sumner, Bonnie
    Fan, Brenda Chen
    Lindsey, Brock
    Schoonover, Carrie
    Schwartzbach, Cary C.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2021, 52 (10): : 3051 - 3059
  • [47] IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH OLOKIZUMAB TREATMENT IN PATIENTS WITH ACTIVE, MODERATE TO SEVERE RHEUMATOID ARTHRITIS WHO HAD FAILED PREVIOUS ANTI-TNF THERAPY: RESULTS FROM THE RA0056 DOUBLE-BLIND, RANDOMIZED CONTROLLED STUDY, AND RA0057, ITS OPEN-LABEL EXTENSION
    Genovese, M.
    Fleischmann, R.
    Furst, D.
    Janssen, N.
    Carter, J.
    Dasgupta, B.
    Pitzalis, C.
    Vasyutin, I.
    Kaviarasu, T.
    Krotkova, A.
    Durez, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 718 - 719